{"name":"SpringWorks Therapeutics, Inc.","slug":"springworks-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Nirogacestat oral tablet","genericName":"Nirogacestat oral tablet","slug":"nirogacestat-oral-tablet","indication":"Desmoid tumors (aggressive fibromatosis)","status":"phase_3"}]}],"pipeline":[{"name":"Nirogacestat oral tablet","genericName":"Nirogacestat oral tablet","slug":"nirogacestat-oral-tablet","phase":"phase_3","mechanism":"Nirogacestat inhibits gamma-secretase, reducing the production of Notch intracellular domain and downstream signaling that drives abnormal cell proliferation in desmoid tumors.","indications":["Desmoid tumors (aggressive fibromatosis)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOVGNVUHpiMzRkMER2SVNUTHVkbHIwbTlxaE43Snk1dUdacEdJU1FvV21JSVlXLUhyU3VFNmNHaDN1M0E5eWRYZ2lRWjROOWlOVkQxNm04QXFkX1lTNGZ6R3I4Y3Vobm5vbG9JLThCZVlKUS0xNmF5cG9RbXdFanc3N1dVNVFLZktic1JnU0hzTC14M1JTT3AxZGw4TnY1QzQ3NnZjWEVKYnpWN25PZW8tM01CbHFYRWdoSDdLUVVkX29rSXUxdVE?oc=5","date":"2025-08-20","type":"regulatory","source":"European Pharmaceutical Review","summary":"Merck’s SpringWorks Therapeutics gains European approval for Ogsiveo - European Pharmaceutical Review","headline":"Merck’s SpringWorks Therapeutics gains European approval for Ogsiveo","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNM1pOa3IwTUxodktJck4xQTBSY0JWMGx1cmdQTldsSnV5LXROQ1R0MzZ4b2xVUGdXTzQ5YWVvSFdYSmlXOHhacVdfTHlTZGc4My1HYlBLSXZRWW9TdHBuWjgzTm9DU2gyQW5lWUpnN1dfc2RYUEViVWJSUzFPUGx2TGZHbzltZVlHblVMVUhPQWRwSktLSVhJVlBUdTJFTGFJd1pn?oc=5","date":"2025-07-31","type":"deal","source":"DCAT Value Chain Insights","summary":"Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025 - DCAT Value Chain Insights","headline":"Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPYU1iejI4b0xhMzVkVm5pbjZ6RW9aYU9JdnhnbXVNd2htbUN2Tmx4VEhqbkdXSmF4dkxfSERKaXNWZ3FnWU84Ni1Xc29qd29GMXZWWjVMT05US1paSUJwYzhfajFaOG1CRUhoRmpjb2JmdEdPYVZJa1FnSHQ2YnJCSHE5SFE5d1NUbmtYUg?oc=5","date":"2025-07-01","type":"pipeline","source":"Merck Group","summary":"Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business - Merck Group","headline":"Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPVDg4QkVpM2tiZkhPVXVGUHk2UWc0TENnUjRYY1R0Q3JidGVfSUwzVTdJQ2dQUm9GQWNvbjd4YmttWDFTWXJ6MnBQZnFTd2s3Z0Q5RndJWGNQSzBnaHRmOUZ3Wk5SNGx5cHA4Q2I0TXYyV2huODQ4d09oRVVUR2VsS0xJMDdoRFVLOHNmZFBmMjZidk0wY29iWTE0bVFWNzVJcUcyWGtLRElLQzNkZXA1MWVrdDNYWWxS?oc=5","date":"2025-07-01","type":"deal","source":"Contract Pharma","summary":"Merck KGaA, Darmstadt, Germany Acquires SpringWorks Therapeutics for $3.4M - Contract Pharma","headline":"Merck KGaA, Darmstadt, Germany Acquires SpringWorks Therapeutics for $3.4M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPRXdqRmx0LXZ1dGFYT0trOEVRYzZqdm9XZDZJNU5JYlpQWWs1Ql9wam9yQ1BDYXVrMmR6NzdUSjVYVXBTbjMtOEo1QlNqZzczbU9ZZ0lVNDJWZ2RYOHZTYmlNWjF2aTdjY09VNmZfZWlrTTBkak9ZNmRTQ2JLYjRyNjNxMjVMYnN5cEtSZWZ3T0YzRlpHQVlSemVXREtXUQ?oc=5","date":"2025-04-30","type":"pipeline","source":"CT Insider","summary":"Stamford-based drug developer for rare cancers and tumors sold for $3.9 billion to German company - CT Insider","headline":"Stamford-based drug developer for rare cancers and tumors sold for $3.9 billion to German company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQWFpJOEtwNE9zQ01nczNmMFFZSlpwb2hoOFdjS3FTNTJBTG41NHd0MUQwRDljX1V1cDhQcHRmSEIzR0twVlZkUGtfZTQzbDBpTWJka1o1cXU2YVlQYWNzeVM4X3M0cXBoVDRFTkdtQW9mTHV4ZGF0TVVIVktzUzBXRlBXYkQzbUVFbUlPX1pGVk1aNTlm?oc=5","date":"2025-04-28","type":"deal","source":"BioPharma Dive","summary":"Merck KGaA to buy biotech SpringWorks for $3.9B - BioPharma Dive","headline":"Merck KGaA to buy biotech SpringWorks for $3.9B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNTjBVSGhwTm9kZk43OUdfWEwyMFZCZS04Sklrc0tfOGpfWnZIb3M5ekFxSFdSM284T3B4aVh6RUxtNU1RMDIzN2d6TUFDakdSQVlKTFlUaWlKNTNrUjVldFh1eWdzMm84anFGS0NWYjdPVXE3QVE2V29WQnpUN1ZvYWtTWnB5SkVKSnNiLUZVUQ?oc=5","date":"2025-04-28","type":"deal","source":"Fierce Pharma","summary":"Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks - Fierce Pharma","headline":"Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOcVhrZmJqNEE3c2pEV2c0bFlzM3d2UFVtVlBOSVZpeVVLZ21UVE9JNTdQSHRXTlprWGN6QzZacUtLcUNybjdQUTZYMzBPRVJwOXQzRk5CanUxVUZuVWs3ZFM1aGFScjZ5UGxIeHFTNU9DRGdfdnZ3ZFdkSEx1bkEtdTQ1dW5velFyRENRRFc0ODlkTGNOdFBrSQ?oc=5","date":"2025-04-28","type":"deal","source":"Bloomberg.com","summary":"Watch Merck KGaA to Buy Springworks for $3.9B - Bloomberg.com","headline":"Watch Merck KGaA to Buy Springworks for $3.9B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQeGcwc0JFLVpFUlpZY1RpUjFaUFROMmdOaEZLR0JVZWN6SkNCbTZIblByY0JuWTlXQkpDbkZqanV5UVBxbjJqN3ZYUkJQOURGX3dVMzVBU3Q1MlhoT1JHNmxWMUhBMW5RM19Gd0pfeDEzVlhfSnZkSjU4dDdYdnIzR3BCZExaQVl4RWo1ZHQxaEZISjhhR0F3Tk1BU1pGbVNidjhfaFpheWlSV19sOVk2UzhsaHA?oc=5","date":"2025-04-28","type":"pipeline","source":"MedCity News","summary":"Merck KGaA’s Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition - MedCity News","headline":"Merck KGaA’s Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxOazc1em1WSlJTY1hZcVp6Y2gyWVhNTC05blRybGU3dEdYWnRMSVFpRXd1UlZHcHplOTA3NFBUWF8xVHZJTkJVM25ueG41bXhpVU9ZNnVpeHVXckJZeDdPSFFRSERCSjJwejQ3UnBtWlY1aVRWV0VNZkk1UkpmM0FWVnVYR0x2UEpQOGdVQjQ5a0FJRU5TMnNiUGhpUWFIWGJocElWVVlqdFlSSU1qSGxHZ1JDeERocllhQUZ2VXlVa2dWVHF0eG9ScEh2M2kxcnRfX1NYVFVnQjR6cENaX0ZmWlFIcG14QU5mclFsblctT3ZJdkFCU2J0SUMxWmtxbFZWelBXTFV2R1NsT0RzQWxhQVNBZG82NnZSRzF5SF9Oci1ZNTJp?oc=5","date":"2025-04-27","type":"deal","source":"Business Wire","summary":"Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business - Business Wire","headline":"Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks Therapeutics to Accelerate Sustainable Growt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQUFZTbkc2NWdQQUFaRVZPcnp0NXloVUtsRk5kTTlFVThnMGY3UW5aMExsOTc5Uk43V0lhNXBwR3FHZ01OcEptd2tmQ3B5dVltWjhqWW5kNUVrSDNFYUpIaVU3S3pnbTVsMTZYUGRDY1dFeWtDLU8zYUoxczBlcnBKb3BkRUhYX0psOVZJUmFYdk9GTVk3ek1nRDFjSVJETUZ6OF9OU3B0Z2ZFSjIzRFM5Z2tneHBDb3FUbUtsR2hJMWs5TEluYVZJQlZUSG5KZlhEN0tBVlQ3aw?oc=5","date":"2025-04-25","type":"deal","source":"reuters.com","summary":"Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion - reuters.com","headline":"Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPeUJDTDlBR2hzem5GS19HREtoZVRaZlJIZmgwWE85eDZBcXNKbU1OT3ZZX0NPd3JrMWV0dmUxSXNaQjJ0NTJQaWJKbmhlUFVaU0ppTmZoRDk4ZkdWdm1EVW15aEkzdlRsNm1oNGlxc0VCZGxTVFZIR0Nkd0dkT3hfd3Nn?oc=5","date":"2025-04-21","type":"pipeline","source":"Pharma Voice","summary":"How a scrapped Pfizer drug became a winner for SpringWorks - Pharma Voice","headline":"How a scrapped Pfizer drug became a winner for SpringWorks","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}